Global Pharmaceutical and Medical Gases Market Size By Type (Product Type I, Product Type II), By Application (Application I, Application II), By Region, And Segment Forecasts, 2023 to 2032

The Global Pharmaceutical and Medical Gases Market was valued at USD 15.7 billion in 2023 and is projected to reach USD 27.4 billion by 2031, growing at a CAGR of 7.1% during the forecast period of 2023–2031. This market is experiencing substantial growth due to the rising demand for medical-grade gases in surgical, therapeutic, and diagnostic applications, coupled with the increasing prevalence of chronic diseases and the expansion of the healthcare and pharmaceutical sectors. Medical gases like oxygen, nitrous oxide, carbon dioxide, and nitrogen are indispensable in hospitals and research facilities, fueling consistent demand globally.

Drivers:

1. Increasing Demand for Chronic Disease Treatment:

Rising incidences of respiratory diseases, cardiovascular disorders, and cancer are significantly contributing to the demand for pharmaceutical and medical gases, particularly oxygen and anesthetic gases.

2. Growth in Surgical and Emergency Care Procedures:

The growing number of surgeries, ICUs, and emergency healthcare facilities across developed and developing countries is boosting the consumption of medical gases.

3. Technological Advancements in Gas Delivery Systems:

The market is benefiting from innovations in gas cylinders, pipeline systems, and homecare respiratory therapy equipment that enhance the safe and effective delivery of gases.

Restraints:

1. Stringent Regulatory Framework:

The pharmaceutical and medical gases market faces challenges due to complex regulatory guidelines related to storage, transportation, and purity standards.

2. High Operational Costs:

Establishing facilities for the production and distribution of medical gases involves substantial capital investment, which can be a barrier for new entrants.

Opportunity:

1. Expansion in Home Healthcare Services:

With the increasing aging population and shift toward home-based care, there is a growing opportunity for medical gas delivery systems used in home oxygen therapy and palliative care.

2. Untapped Potential in Emerging Markets:

Countries in Asia-Pacific, Latin America, and Africa are expanding their healthcare infrastructure, providing untapped opportunities for market players to expand their footprint.

Market by System Type Insights:

In 2023, the Oxygen Gas segment dominated the market due to its wide application in surgeries, emergency response, and respiratory treatments. However, the Specialty Medical Gases segment, which includes gases used in advanced diagnostics and therapies, is projected to witness the highest growth, driven by rising demand in biotechnology and pharmaceutical research.

Market by End-use Insights:

The Hospitals & Clinics segment held the largest market share in 2023, as these facilities are primary consumers of medical gases for a wide range of patient care applications. The Home Healthcare segment is poised for rapid growth during the forecast period, supported by increasing demand for portable oxygen concentrators and home-based respiratory treatments.

Market by Regional Insights:

North America led the global pharmaceutical and medical gases market in 2023, supported by a well-established healthcare infrastructure, strong reimbursement systems, and high adoption of advanced medical technologies. Meanwhile, the Asia-Pacific region is projected to grow at the fastest pace due to rapid healthcare system expansion, government investments, and increasing prevalence of chronic diseases in countries like China and India.

Competitive Scenario:

Key players in the Global Pharmaceutical and Medical Gases Market include Air Liquide, Linde plc, Air Products and Chemicals, Inc., Messer Group GmbH, Taiyo Nippon Sanso Corporation, SOL Group, Praxair Technology Inc., Matheson Tri-Gas Inc., Atlas Copco AB, and GCE Holding AB. These companies are actively engaging in strategic collaborations, acquisitions, and capacity expansions to strengthen their global presence.

Scope of Work – Global Pharmaceutical and Medical Gases Market

Report Metric Details

Market Size (2023) USD 15.7 billion

Projected Market Size (2031) USD 27.4 billion

CAGR (2023–2031) 7.1%

Market Segments By System Type (Oxygen, Nitrous Oxide, Carbon Dioxide, Nitrogen, Specialty Gases), By End-use (Hospitals & Clinics, Home Healthcare, Pharmaceutical & Biotechnology Companies, Diagnostic Centers)

Growth Drivers Rising chronic diseases, expanding surgical needs, and innovation in gas delivery systems

Opportunities Emerging markets expansion, rise in home healthcare services

Key Market Developments:

May 2023: Linde plc expanded its high-purity gas production facility in Germany to support increasing demand in pharmaceutical applications.

August 2023: Air Liquide launched a new portable oxygen concentrator targeting the homecare segment in North America and Europe.

January 2024: Air Products signed a strategic agreement with a major healthcare group in India to establish an integrated medical gas pipeline network across several hospitals.

FAQs:

1) What is the current market size of the Global Pharmaceutical and Medical Gases Market?

The market was valued at USD 15.7 billion in 2023.

2) What is the major growth driver of the Global Pharmaceutical and Medical Gases Market?

The major growth driver is the increasing demand for medical gases due to the rising prevalence of chronic diseases and surgeries.

3) Which is the largest region during the forecast period in the Global Pharmaceutical and Medical Gases Market?

North America is the largest region in terms of market share.

4) Which segment accounted for the largest market share in the Global Pharmaceutical and Medical Gases Market?

The Hospitals & Clinics segment held the largest share in 2023.

5) Who are the key market players in the Global Pharmaceutical and Medical Gases Market?

Key players include Air Liquide, Linde plc, Air Products and Chemicals, Inc., Messer Group GmbH, and Taiyo Nippon Sanso Corporation.